Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
At 2.4 mg weekly, average weight loss reached about 15% over 68 weeks. Response varied widely: 86% lost at least 5%, 69% lost 10%, half lost 15%, and about one-third lost 20%. These results describe that cohort rather than a universal forecast
From sourcing and handling to packaging and testing, we prioritize product integrity at every step
What is documented is the outcome: a research protocol that treats 4.5 mg as the target is going past the dose the sponsor advanced after seeing the complete phase 2 dataset
Side effects that occur less frequently are lightheadedness, nausea, fatigue, headache, dizziness, warmth, or flushing
)
